“Bufalin inhibits the growth and epithelial to mesenchymal transition of human gastric cancer cells via modulation of MEK/ERK pathway”, Bangladesh J Pharmacol, vol. 16, no. 1, pp. 27–33, Jan. 2021, doi: 10.3329/bjp.v16i1.50548.